Literature DB >> 31737415

Functional Testing of a Skin Topical Formulation In Vivo: Objective and Quantitative Evaluation in Human Skin Scarring Using a Double-Blind Volunteer Study with Sequential Punch Biopsies.

Rubinder Basson1, Mohamed Baguneid2, Philip Foden3, Rawya Al Kredly4, Ardeshir Bayat1.   

Abstract

Objective: Many topicals claim an efficacious role in skin scar management with limited evidence. Our aim is to present a clear format for functional testing of a skin scarring ointment, using noninvasive and invasive measurements, categorizing findings under the physiological, structural, and mechanical parameters of a scar. Approach: A double-blinded, randomized volunteer research study of 45 subjects receiving an ointment composing of natural ingredients against a widely used antiscarring topical used as a positive control with temporal sequential punch biopsies (up to 16 weeks) was evaluated using noninvasive quantitative devices and validated by gene and protein studies.
Results: Outcome measures included physiological, mechanical, and structural features of scars. Significant non-invasive findings included an increase in skin hydration (p < 0.05) at week (W) 4, 8, and 12, and elasticity (W16; p = 0.009). These findings were validated by immunohistochemistry (IHC) and quantitative real-time PCR (qRT-PCR). Hyaluronic acid IHC (W4 p = 0.014, W12 p = 0.034, and W16 p = 0.042), qRT-PCR (W16 p = 0.049); Collagen I (W16 p = 0.034, and 0.049) IHC and qRT-PCR, respectively. Collagen III qRT-PCR (W12 p = 0.035, and W16 p = 0.32); elastin IHC (W12 p = 0.044); and fibronectin IHC (W4 p = 0.009, W12 p = 0.038, and W16 p = 0.026). Innovation: Utilizing this model allows for quantitative, objective evaluation of any topical, where previously there has been a paucity of relevant methods to evaluate their effect. Conclusions: The positive effect of a topical formulation with an unknown mechanism of action on early cutaneous scar maturation over progressive sequential time points is now evidenced using noninvasive and invasive techniques with the findings categorized on the basis of scarring parameters. Copyright 2019, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  MEBO Scar; clinical trial; scar ointments; scars; skin; skin scarring; topicals

Year:  2019        PMID: 31737415      PMCID: PMC6855292          DOI: 10.1089/wound.2018.0864

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  19 in total

1.  Improving scar quality: a prospective clinical study.

Authors:  Bishara S Atiyeh; John Ioannovich; Christian A Al-Amm; Kusai A El-Musa; Ruwayda Dham
Journal:  Aesthetic Plast Surg       Date:  2002 Nov-Dec       Impact factor: 2.326

2.  Scar quality and physiologic barrier function restoration after moist and moist-exposed dressings of partial-thickness wounds.

Authors:  Bishara S Atiyeh; Kusai A El-Musa; Ruwayda Dham
Journal:  Dermatol Surg       Date:  2003-01       Impact factor: 3.398

Review 3.  Skin scarring.

Authors:  A Bayat; D A McGrouther; M W J Ferguson
Journal:  BMJ       Date:  2003-01-11

Review 4.  Topical treatments for hypertrophic scars.

Authors:  Joanna M Zurada; David Kriegel; Ira C Davis
Journal:  J Am Acad Dermatol       Date:  2006-09-18       Impact factor: 11.527

Review 5.  Non-invasive objective devices for monitoring the inflammatory, proliferative and remodelling phases of cutaneous wound healing and skin scarring.

Authors:  Sara Ud-Din; Ardeshir Bayat
Journal:  Exp Dermatol       Date:  2016-06-15       Impact factor: 3.960

6.  Assessment of the Combined Efficacy of Needling and the Use of Silicone Gel in the Treatment of C-Section and Other Surgical Hypertrophic Scars and Keloids.

Authors:  Gabriella Fabbrocini; Claudio Marasca; Sadia Ammad; Benedetta Brazzini; Rosanna Izzo; Marianna Donnarumma; Giuseppe Monfrecola
Journal:  Adv Skin Wound Care       Date:  2016-09       Impact factor: 2.347

7.  Moist exposed burn ointment promotes cutaneous excisional wound healing in rats involving VEGF and bFGF.

Authors:  Qian-Li Tang; Shan-Shan Han; Jing Feng; Jia-Qi Di; Wen-Xi Qin; Jun Fu; Qiu-Yan Jiang
Journal:  Mol Med Rep       Date:  2014-01-28       Impact factor: 2.952

8.  Role of epidermal stem cells in repair of partial-thickness burn injury after using Moist Exposed Burn Ointment (MEBO(®)) histological and immunohistochemical study.

Authors:  M R El-Hadidy; A R El-Hadidy; A Bhaa; S A Asker; S A Mazroa
Journal:  Tissue Cell       Date:  2014-01-27       Impact factor: 2.466

9.  Acute cutaneous wounds treated with human decellularised dermis show enhanced angiogenesis during healing.

Authors:  Nicholas S Greaves; Syed A Lqbal; Julie Morris; Brian Benatar; Teresa Alonso-Rasgado; Mohamed Baguneid; Ardeshir Bayat
Journal:  PLoS One       Date:  2015-01-20       Impact factor: 3.240

Review 10.  A comprehensive evidence-based review on the role of topicals and dressings in the management of skin scarring.

Authors:  G P Sidgwick; D McGeorge; A Bayat
Journal:  Arch Dermatol Res       Date:  2015-06-05       Impact factor: 3.017

View more
  3 in total

1.  Assessment of Transdermal Delivery of Topical Compounds in Skin Scarring Using a Novel Combined Approach of Raman Spectroscopy and High-Performance Liquid Chromatography.

Authors:  Rubinder Basson; Cassio Lima; Howbeer Muhamadali; Weiping Li; Katherine Hollywood; Ludanni Li; Mohamed Baguneid; Rawya Al Kredly; Royston Goodacre; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-01       Impact factor: 4.730

2.  Classification of Distinct Endotypes in Human Skin Scarring: S.C.A.R.-A Novel Perspective on Dermal Fibrosis.

Authors:  Sara Ud-Din; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-04-20       Impact factor: 4.730

Review 3.  Pharmaceutical Prophylaxis of Scarring with Emphasis on Burns: A Review of Preclinical and Clinical Studies.

Authors:  Peter D'Arpa; Kai P Leung
Journal:  Adv Wound Care (New Rochelle)       Date:  2021-02-24       Impact factor: 4.947

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.